Boundless Bio
are detected broadly across different cancer types but not in normal tissue or blood | Boundless Bio
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2024
Slide
16 of 51
Related slides by other companies
Kymera
Investor Day
December 2021
tissue selective degradation drives increase of therapeutic index | Kymera
Cloudflare
Investor Day
May 2022
broadly diversified customer base type geography top customers | Cloudflare
AstraZeneca
Investor Day
January 2022
are the next pillar for in oncology | AstraZeneca
BioAtla
Investor Presentation
January 2024
cab selectively active in tumor thereby reducing immune related adverse events | BioAtla
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io